In another study, IPF patients with increased serum KL-6 levels during follow-up had a significantly steeper decline in FVC than those without increased KL-6 (−201 vs. −50.7 mL/year; p = 0.0001). Here, MUC1 is linked to idiopathic pulmonary fibrosis.